Drug Profile
Research programme: type-1 diabetes mellitus therapies - JDRF/Pfizer
Latest Information Update: 28 Dec 2017
Price :
$50
*
At a glance
- Originator JDRF; Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 1 diabetes mellitus
Most Recent Events
- 28 Dec 2017 No recent reports of development identified for research development in Type-1 diabetes mellitus in USA
- 24 Nov 2013 Early research in Type-1 diabetes mellitus in USA (unspecified route)